Nocturnal hemodialysis was started more than 6 1 /2 years ago in Toronto in an attempt to improve patient outcomes and quality of life. The method was intended to combine the benefits of the long dialysis reported from Tassin (1, 2) with daily hemodialysis (3, 4) . The experience and the results will be summarized.
Nocturnal hemodialysis is done at home during sleep by the patient or a partner (5). The length of dialysis, reflecting the preferences of the patient, ranges from six to twelve hours, usually eight. Most patients dialyse for six nights a week, but some have opted for seven nights. Because of the hemodynamic stability provided by the long and frequent dialysis, no partner has been required. Blood flow has been variable (150-500) usually 200-300 ml/min; and dialysate flow has also been variable (100-800), usually 300 ml/min. Any hemodialysis machine can be used for nocturnal hemodialysis, although the Fresenius 2008H has provided dialysate flow lower than 300 ml/min. Dialysate composition has been sodium 140mEq/L, potassium 2 mEq/L and bicarbonate 28-35 mEq/L. Dialysate calcium averaged 3.2 mEq/L (higher than in conventional hemodialysis) and most patients have added sodium phosphate at variable concentrations (0-4.5 mg/dl) to the acid or bicarbonate concentrate to prevent hypophosphatemia.
Delaying dialyser reprocessing has been practiced by storing the rinsed dialysers in a small refrigerator at home and exchanging them at the center, only once a week, with reprocessed ones (6). Dialyser reuse is optional.
Central venous catheters as well as AV fistulas and grafts can be used, and proper techniques prevent catheter disconnection or air embolism during the night (5). The infection rate associated with catheters, at about 1.5/1000 days, has been relatively low, and the catheter survival has been higher than in centre hemodialysis (7). Plastic cannulas and steel needles have been used for fistulas and grafts. The buttonhole technique of cannulation has been used for fistulas. Several patients have used a single needle system, which has provided adequate flow, decreased number of cannulations, and increased safety.
'Live' remote monitoring of the machine functions is achieved through a telephone or Internet connection and the patients are called if not awakened by the alarms. Although monitoring provides patient reassurance and improved compliance, it is considered optional. Inexpensive over-the-counter alarm devices have been used to detect blood leaks around the fistula needle and dialysate or blood leaks on the floor. It is expected that in the future the remote monitoring will include such devices as well as unobtrusive continuous vital signs measurements.
Fifty-two patients have been trained and 41 patients are currently on nocturnal hemodialysis at the Humber River Regional Hospital, in Toronto. The known total number of patients currently on nocturnal hemodialysis internationally is estimated at more than 100. Nocturnal hemodialysis has been used both as a rescue treatment in patients with significant co-morbidities or to improve the quality of life and increase vocational rehabilitation. The longest period on the treatment is 6 1 /2 years and the average is 30 months.
Laboratory tests were improved impressively. Equilibrated Kt/V of about 1 was achieved nightly using a dialysate flow of 100 ml/min (5) or a single pool weekly Kt/V of more than 13 as was found by O' Sullivan (8). Standard Kt/V, as defined by Gotch (9), of 4-5 on nocturnal hemodialysis is more than twice that achieved by conventional hemodialysis and CAPD, suggesting that nocturnal hemodialysis is the dialysis of choice for large patients. Phosphate control has been excellent despite the high phosphate diet and discontinuation of phosphate binders on all patients (10) . Phosphate removal has been twice as high as on conventional hemodialysis, requiring the addition of phosphate into the dialysate in the form of sodium phosphate (Fleet enema/Fleet Phospho-soda ® ) in 75% of the patients. ß2-microglobulin removal was four times as high as conventional hemodialysis, leading to a decrease in the ß2-microglobulin serum levels (11) .
Quality of life improved. Uremic and dialysis related symptoms subsided and patient satisfaction has been considerable. We used the Sickness Impact Profile (SIP), SF-36 and the Beck depression index prior to and after the conversion of 18 patients to nocturnal hemodialysis (12) . The SIP score and the Beck depression index
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Hypertension is easily controlled and almost all antihypertensives can be discontinued. Decrease in the 'dry weight' and occasional use of a small dose of a betablocker has been universally successful. The dose of EPO decreased by about 40%, although the effect of the administration of intravenous iron has not been fully separated (13) .
Nocturnal hemodialysis has been shown to correct sleep apnea (14) , a highly prevalent condition in the ESRD population and a recently considered as an independent mortality risk factor (15) .
Although the effect on bone disease has not been fully elucidated, the excellent phosphate control and the ability to suppress PTH levels by increasing dialysate calcium promises to improve bone disease. DEXA bone densitometry has helped adjust the dialysate calcium. In one patient, tumorous extraosseous calcifications dissolved within 3-6 months on nocturnal hemodialysis (16) . Although increasing the dialysis dose decreases mortality, the optimal dose is currently debated. A significant part of patient morbidity and likely mortality is related to the so-called 'unphysiology' of dialysis (17) . It is likely that the unexpected ability of CAPD to provide similar outcomes to hemodialysis (18) is related to the smoothness of this regimen. Although the results of the ongoing HEMO study on the effects of a higher dialysis dose are expected with interest, they may not be applicable to the long or frequent dialysis regimens. In these regimens, the higher dialysis dose may have a more beneficial effect, while the potential benefit of higher dialysis dose on conventional hemodialysis may be hampered by the morbidity and mortality induced by the 'unphysiology' of the thrice a week regimen. Recently Leypoldt et al (19) have demonstrated an association of increased middle molecule clearance to patient survival. Nocturnal hemodialysis provides a four-fold increase in the middle molecule clearance and this could provide a significant benefit (11) . The unique success of nocturnal hemodialysis in phosphate control is promising to have a significant effect on outcomes, especially in view of the realization of the inexorable progression of vascular calcifications even in young patients on dialysis.
Because of its high frequency the cost of consumables is higher on nocturnal hemodialysis. Furthermore, the purchase of the dialysis machine, as well as the reverse osmosis water treatment equipment and the training of the patients add further to the cost of the method. Conversely, the decreased labour cost associated with no need for personnel during the dialysis makes the overall direct cost of the method comparable or lower than the cost of in-centre hemodialysis. Decreased morbidity and lower hospitalization rates have been reported, but hard prospective randomized data are still missing (20) . The savings related to the decreased use in EPO, antihypertensives and phosphate binders, especially the promising but expensive treatment with sevelamer (Renagel ® ), are significant. Detailed analysis by the Project Hope suggested yearly savings of about US $9,500 by nocturnal hemodialysis (21) . This analysis is applicable only in countries with high labour to consumable ratio. The cost of nocturnal hemodialysis is likely to be higher than conventional hemodialysis in countries where the ratio of labour to consumable cost is low.The main impediment to the increase in the penetration of nocturnal hemodialysis is the issue of cost reimbursement. In most countries, the cost of the components of the care of the renal patients is born by different payers. The providers of dialysis have to pay for the higher cost of nocturnal hemodialysis, but cannot harvest the financial benefits from the improved quality in the form of decreased hospitalization rates or decreased medication costs. In a global or capitated system, nocturnal hemodialysis almost certainly provides financial benefits from the decrease in hospitalization rates and medication cost. Furthermore, other societal benefits such as decreased transportation costs or benefits from the vocational rehabilitation of the patients add to the financial benefits.There is a need for studies aiming to capture prospectively the financial information in support of these views. Another impediment for the adoption of home hemodialysis is the lack of patient-friendly hemodialysis machines. Recently, there has been increasing interest by the industry in daily hemodialysis (22) , which will hopefully lead to the creation of simpler hemodialysis machines. Lastly, the decline in home hemodialysis over the last decades has decreased the familiarity of the providers with this modality. Renewed efforts to train nephrologists as well as nurses on home hemodialysis will help overcome the current inertia.
A significant benefit from the experience with nocturnal hemodialysis has been the realization that patients can improve substantially by good quality dialysis and that their plight is related to the inadequate or poor quality treatment. In the eyes of patients or caregivers who experienced the Nocturnal hemodialysis results of this regimen, nocturnal hemodialysis is a breakthrough in the provision of treatment of ESRD.
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